joobz
Tergiversator
- Joined
- Aug 31, 2006
- Messages
- 17,998
Well, We could easily see if this was true by plotting the number of new medical products produced by a country vs. the insurance premiums paid.Beerina seems to think that the huge over-the-odds that America pays for its healthcare goes (almost entirely) to fund medical research, and this is America's contribution to the world - to subsidise medical advances eventually benefitting even the cheapskate countries who don't contribute because they have universal healthcare. He believes that if America stops doing this, then medical progress will slow down so much that it will cost millions of lives 100 years or so down the line.
In fact the huge over-the-odds paid by America goes quite a lot of places, including insurance company overheads and profits, unnecesary interventions carried out for defensive reasons, and complicated almoning and means-testing of non-universal benefits. Paying over the odds for pharmaceuticals is part of it, but by no means the largest part.
Even so, the over-pay for pharmaceuticals goes partly into pharmaceutical companies' profits, and the part that does fund medical research is far more likely to be funding the production of another "me too" drug to compete with a competitor's very similar product than it is to contribute to a genuine medical advance.
Beerina also appears to think that innovation is stifled within universal healthcare systems, because the doctors "work for the government". In fact, doctors with a penchant for research can pursue that career goal just as easily in a universal system as in an insurance-funded system. I suspect, possibly even more easily, as they don't have insurance companies standing between them and patients they believe would benefit from an experimental procedure.
He's been told this a dozen times, but he never addresses the points raised. It's possible he doesn't even read what's posted after he makes his hit-and-run posts.
Rolfe.
and compare this to the # of new medical products vs. government research dollars spent.
I already know the latter has a very strong correlative result. (japan and US typically lead, with Germany and UK also strong players).